Business Analyst

Claritas Rx · United States (Remote) · Full-time · Posted 2026-09-07

Salary: USD 115,000–125,000

Workplace: remote

Department: Delivery

Description

Who We Are

Claritas Rx uses AI and predictive modeling to help rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete view of the patient journey with purpose-built technologies, we predict and resolve access challenges before they disrupt care, combining advanced analytics, real-world data, AI, and CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. Our mission is to ensure patients with chronic, life-threatening diseases receive the support that enables the greatest benefit from their therapy. Simply put, our promise is progress for every patient journey.

This is the opportunity to help shape a first-in-industry digital health solution alongside a team of mission-driven professionals. We were named one of Inc.'s Best Workplaces in 2025 and recognized on the Inc. 5000 list for two consecutive years (2025 and 2026), and our team genuinely respects and supports each other. We thrive on being fast-paced, innovative, and results-driven, and our employees enjoy a flexible, collaborative work environment, unlimited PTO, stock options, and a growing set of tools and technology to drive innovation for our customers.

The Position

Our Ascend® platform represents the next generation of our delivery capability — a standardized, scalable implementation model that enables faster, higher-quality client onboarding across our specialty pharmacy data ecosystem.

The Business Analyst is the primary technical executor of the Ascend platform configuration. The top expectation of this role is the ability to lead and manage spec negotiations with data partners — ensuring that inbound and outbound data file specifications are aligned with the Ascend data model before configuration work begins. This requires both deep technical fluency in specialty pharmacy data structures and the communication skills to drive data partners toward compliant, complete specifications without compromising go-live timelines.

Working from the Configuration Blueprint produced by the Delivery Director, the BA owns all data mapping, platform configuration, and internal quality assurance before any client-facing testing begins. The BA operates as a critical resource within the Ascend implementation team — interfacing with Engagement Managers, Delivery Directors, and Customer Engineering — and is expected to communicate capacity constraints proactively given the demands of a multi-client portfolio.

As a member of the Delivery and Operations team, the BA is responsible for executing implementation configuration work, conducting rigorous internal QA, and ensuring that nothing advances to UAT without sign-off. The BA is the standard-vs-custom decision support layer for data: identifying when client requests require escalation to Product or Customer Engineering versus when they can be addressed within the standard data model. Role is primarily remote with occasional travel requirements.

Key Accountabilities

Data Partner Spec Negotiation ★ Primary Accountability

Lead spec negotiations with specialty pharmacy and other data partners to ensure inbound and outbound file specifications are fully aligned with the Ascend data model before configuration begins — this is the single most critical function of the role
Review partner-submitted data specifications for completeness, field-level accuracy, and model alignment; document gaps and drive resolution directly with the data partner
Negotiate field mappings, list-of-values (LOVs), file formats, and delivery cadences with data partners, escalating to the Engagement Manager only when partner alignment cannot be achieved at the working level
Validate test files against finalized specifications and flag discrepancies before data enters the pipeline; maintain a clear record of spec versions and sign-off status across all active partners
Translate data partner constraints into actionable decisions for the implementation team — identifying what can be resolved through configuration, what requires a spec exception, and what must route to Customer Engineering

Platform Configuration & Data Mapping

Own all platform configuration work: data mapping, configuration tooling, business logic implementation, and front-end reporting setup — all driven by the Configuration Blueprint received from the Delivery Director
Review data specifications produced in collaboration with the Engagement Manager; proactively flag data model mismatches or gaps prior to configuration work beginning
Load data into the pipeline using configuration tooling once specifications are finalized and signed off by relevant stakeholders
Collaborate with Customer Engineering on the handoff of data mapping for standard data model onboarding; provide CE with the context needed for custom build workstreams

Internal QA & Quality Standards

Conduct internal QA testing of all configuration work prior to partner or client-facing testing — nothing advances to UAT without BA sign-off
Track and resolve defects identified during internal QA and UAT for all configuration-related issues
Perform quality control procedures to assure configurations and data quality meet acceptance criteria prior to go-live
Develop and maintain QA documentation, test case frameworks, and checklists that support repeatable, auditable testing across implementations

Escalation & Non-Standard Request Routing

Identify whether client requests fall within the standard Ascend data model, require configuration adjustment, or require escalation — to Product for roadmap consideration or to Customer Engineering for custom build
Document and route non-standard requests with clear business need descriptions and technical context so that Product and CE can act without re-scoping
Conduct change impact analysis to assess how updates or non-standard requests may affect system performance and configuration decisions

Cross-Functional Coordination

Consult with Engagement Managers on data partner specs, testing timelines, and UAT scheduling to ensure internal readiness gates are met
Coordinate with Delivery Director on receipt and interpretation of the Configuration Blueprint — the primary work input for each implementation
Report blockers, capacity constraints, and escalations to the Engagement Manager proactively; given a typical 1-BA-to-many implementations ratio, early communication of bandwidth risks is a core accountability
Support the Delivery Director and Customer Success with UAT business validation for configuration-related questions

Process, Documentation & Knowledge Management

Facilitate schema normalization of system databases; maintain data dictionaries and file inventories across customer applications
Consults with cross-functional teams to document business requirements, operating procedures, issue resolution processes, and platform configurations that enable efficient implementation
Develop and maintain an operating playbook that details best practices for configuration sequencing, data partner onboarding, and documentation requirements
Write clear, detailed procedures for internal training and be able to train other Business Analysts as the team scales
Support creation and ongoing maintenance of standard UAT test script templates for core Ascend use cases in partnership with the Delivery Director

Who You Are

Skills & Knowledge:

Demonstrated ability to lead data partner spec negotiations — driving alignment on file specifications, field mappings, and LOVs across multiple external partners simultaneously
Excellent written and oral communication — able to document complex data relationships clearly for both technical and non-technical audiences
Ability to prioritize, organize, and execute multiple tasks simultaneously with rigorous attention to detail across a high-volume implementation portfolio
A creative approach to operational problem solving and a relentless passion for quality
Deep knowledge of data management in specialty biotech and/or operations in reimbursement call centers or specialty pharmacies
Familiarity with healthcare data sources — transactional, clinical, and behavioral — including specialty pharmacy data file types (patient demographics, dispense, status, inventory)
Understanding of standard implementation lifecycle frameworks: UAT facilitation, defect triage, QA gating, and go-live readiness
Ability to exercise judgment within broadly defined practices and policies when selecting methods and techniques for configuration decisions

Education & Experience

Required:

Bachelor's degree from a 4-year university
2+ years of relevant experience in an operations role at a biopharmaceutical manufacturer, reimbursement call center, specialty pharmacy, or data management company
Proficient in Microsoft Excel and other analytic tools — specifically data comparison, conditional formulas, data summary, and conversion
Functional knowledge of Microsoft Office suite (Word, PowerPoint, Excel)
Background and experience with the Business Analysis toolkit including systems development lifecycles, problem solving and root cause analysis methods, and the ability to document business process models
Demonstrated ability to manage deliverables across multiple concurrent implementations or client programs

Preferred:

Experience with specialty pharmacy data file specifications, SFTP workflows, and data onboarding processes
Academic training in public health, business administration, and/or operations research
Case management experience in a reimbursement call center or specialty pharmacy
Familiarity with project management tools such as Smartsheet, JIRA, or Confluence
Familiarity with Google Docs, workflow diagram tools, web-based software systems, and relational databases
Experience working within a structured RACI model or implementation team framework

Join Us

We are seeking to add new expertise and perspective to our strong team of experienced professionals. We aspire to a culture of accelerated professional development through: shared learning and collaboration; a respectful and fun work environment; and employee empowerment through the effective use of technology and tools.

We are a highly collaborative team and prioritize opportunities to connect in person. For employees within a reasonable driving distance of each other, we host regional town hall gatherings approximately every other month. These sessions give our teams a chance to come together, share updates, and strengthen relationships beyond day-to-day work.

In addition to our great environment, we offer a competitive salary of $115,000 to $125,000 and benefits package and the opportunity to make a significant impact on a first-in-industry digital health solution. Please send a cover letter along with your resume when applying to the position of interest. Claritas Rx embraces diversity, equality, and transparency. We are committed to building a team that comprises a variety of backgrounds, perspectives, and talents. We believe the more inclusive we are, the better we are.

Join us and discover what it feels like to be part of an environment that rewards ingenuity, risk taking and smart work. It's time to fall in love with what you do!

At Claritas Rx, protecting our candidates is a top priority. If you're applying for a role with us, please note:

•All legitimate opportunities are posted first on ClaritasRx.com. Check there before trusting external listings.

• We believe in meaningful interviews: offers never come after just one phone call or form. Expect multiple video calls to get to know you.

• We never ask for fees or payments of any kind during the hiring process.

• Our People Operations Team will handle your onboarding, and all equipment comes directly from us—no purchases required.

Learn more about how to spot recruitment scams and protect yourself - FBI warning: https://bit.ly/4aDF5wU

Claritas Rx is committed to transparency, integrity, and a safe hiring experience for every candidate. Learn more

https://www.claritasrx.com/about/careers/

Apply

Apply at Claritas Rx

About the company

Claritas Rx provides data integration and analytics for biopharma by unifying data from specialty pharmacies, commercial channels, clinical trials, patient support hubs, and copay cards into a cloud-based system. Its Ascend platform automates data integration and analysis to reveal the patient journey beyond trials, including real-world factors like fill rates and therapy duration. Patient Watchtower uses AI/ML to identify patients at risk of discontinuing treatment so care teams can intervene to support adherence, with daily updates and predictive analytics for prioritization. The company focuses on specialty and rare-disease therapies, especially oncology, to help biopharma firms improve patient adherence, optimize product launches and access, and strengthen commercial performance.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

South San Francisco, California

Founded

2011

Get referred to Claritas Rx

See people who can refer or advise you

Simplify's Take

What believers are saying

May 2026 leadership expansion added Keith Pensabene as CRO, signaling aggressive go-to-market scale.
2026 launches and award wins validate product momentum, especially Patient Watchtower and Omnichannel CRM.
Early adopters reported 12%-40% higher consent fill rates and 11% stronger persistence.

What critics are saying

IQVIA and Veeva own adjacent pharma data workflows, squeezing Claritas Rx enterprise deals.
Client concentration in oncology and rare disease makes any lost anchor account painful fast.
If AI-driven consent or orchestration underperforms, biopharma teams replace Claritas Rx with internal stacks.

What makes Claritas Rx unique

Ascend unifies specialty-pharmacy, hub, copay, and field data into one longitudinal patient view.
Patient Watchtower and Omnichannel CRM connect risk detection with front-line action across therapy journeys.
Consent Clearinghouse centralizes consent across HIPAA, GDPR, CCPA, and state-law workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Unlimited Paid Time Off
Stock Options
Remote Work Options
Flexible Work Hours
Hybrid Work Options

Growth & Insights and Company News

6 month growth

15%

1 year growth

15%

2 year growth

15%

Claritas Rx

Oct 13th, 2026

Claritas Rx appoints biopharma commercial leader Jonathan Witt to Board of Directors.

Claritas Rx appoints biopharma commercial leader Jonathan Witt to Board of Directors. Former Genentech Senior Vice President brings more than 25 years of biopharma experience to guide continued growth and patient impact. South San Francisco, CA, October 13, 2026 - Claritas Rx, the patient journey experts, today announced the appointment of Jonathan Witt to its Board of Directors. Mr. Witt is an accomplished senior executive with more than 25 years of experience in U.S. and global biopharmaceutical roles. He has a proven record of evaluating market opportunities across diverse therapeutic areas, setting development, commercialization, and corporate strategy, building and scaling enterprise capabilities, and transforming organizations to deliver leading customer experiences. Mr. Witt is the Chief Customer Experience Officer at Jazz Pharmaceuticals, where he leads the global commercial organization's evolution to deliver a seamless, differentiated patient and customer experience across all therapeutic areas. Before Jazz, Mr. Witt spent nearly 20 years at Genentech, most recently as Senior Vice President of Genentech Business Operations, a 1,000-person organization spanning omnichannel and customer experience, AI and advanced analytics, and patient access and support. He led the company's Integrated Customer Experience strategy, which delivered $700 million in portfolio revenue in 2024, and guided a multi-year transformation of Genentech's U.S. organization. He previously held vice president roles in pipeline strategy and commercialization, access and distribution, and market analysis and strategy. Earlier in his career, Mr. Witt spent four years at Pfizer in neuroscience new product development and three years in healthcare management consulting with Towers Perrin. He holds an MBA in marketing and strategic management from the University of Chicago Booth School of Business and a BA in economics from Princeton University. "After more than 25 years inside biopharma companies, I know firsthand how much depends on what happens between a prescription and a patient starting therapy," said Mr. Witt. "I've seen how hard it is for commercial and patient services teams to act on access barriers they can't see. Claritas Rx brings visibility to that part of the patient journey, along with the tools to resolve challenges before they disrupt care. I see tremendous potential for Claritas Rx solutions to power meaningful impact for biopharma customers and the patients they serve, and I'm excited to help guide the company's next stage of growth." "Jonathan has spent his career building the kind of customer-centric, data-driven commercial organizations our clients are working toward every day," said Michael Fitzgibbons, CEO of Claritas Rx. "His deep experience in patient access, omnichannel engagement, AI and analytics, and enterprise transformation will be invaluable as we continue to scale and deliver measurable results for rare disease and specialty brands and the patients they serve. We're delighted to welcome him to our Board." About Claritas Rx Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete view of the patient journey with purpose-built technologies, Claritas Rx predict and resolve access challenges before they disrupt care. Its intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com. Ready to transform patient access? See how Claritas Rx can help your organization remove barriers and improve patient outcomes

StreetInsider

Sep 2nd, 2026

Claritas Rx wins Fierce AI Innovation Award for Omnichannel Engagement Strategy.

Claritas Rx wins Fierce AI Innovation Award for Omnichannel Engagement Strategy. E-mail Address StreetInsider.com Top Tickers, 9/2/2026 September 2, 2026 11:37 AM EDT Patient Watchtower(TM) and Patient Services Omnichannel CRM Recognized for Turning Predictive Signals Into Coordinated Action Across the Patient Journey SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)- Claritas Rx, the patient journey experts, today announced it has won the Fierce AI Innovation Award in the Omnichannel Engagement Strategy category. The award recognizes Patient Watchtower(TM) and the Patient Services Omnichannel CRM - two connected AI-powered solutions that let biopharma manufacturers spot risk earlier in the patient journey and coordinate real-time action across every partner helping patients start and stay on therapy. Claritas Rx wins Fierce AI Innovation Award for Omnichannel Engagement Strategy. Patient Watchtower(TM) and Patient Services Omnichannel CRM recognized for turning predictive signals into coordinated action across the patient journey. For patients prescribed specialty and rare disease therapies, the path from prescription to treatment is fragile. Between 31% and 40% of specialty prescriptions go unfilled, and patients whose fill takes longer than 30 days convert at a rate 18 percentage points lower than those who fill sooner. Along the way, a single patient may touch a hub, a specialty pharmacy, a payer, and a copay program within days of each other, each generating data that, on its own, tells only part of the story. Historically, patient services teams have had to wait for a missed fill or a lapsed authorization to signal that a patient had already fallen off therapy. Patient Watchtower and the Patient Services Omnichannel CRM close that gap by connecting prediction to action at every stage of the journey. Patient Watchtower uses AI and machine learning to predict therapy discontinuation, prior authorization denial, and prescription abandonment up to 90 days in advance, with up to 80% precision. The moment a patient is flagged, the Patient Services Omnichannel CRM helps turns that signal into coordinated outreach, connecting case managers, hub partners, and specialty pharmacies in a single workflow so the right partner can respond before a patient drops off therapy. "Every stage of the patient journey generates a signal, but most teams don't see it until it's too late," said Michael Fitzgibbons, CEO of Claritas Rx. "This award reflects work that's built entirely around closing that gap - connecting the moment we detect risk to the moment someone acts on it, so patients start and stay on the therapies they need. That's the promise we make on every patient journey, and it's an honor to see our innovation recognized by Fierce and the industry." Since launching, Patient Watchtower and the Patient Services Omnichannel CRM have delivered measurable results across the patient journey, including a 20% improvement in fill rates, 17% increase in refill rates, a 98% partner response rate within 24 hours, and a significant reduction in manual case management burden - freeing patient services teams to focus on direct patient care rather than administrative reconciliation. The Fierce AI Innovation Awards, presented by Fierce Life Sciences, recognize organizations that are moving beyond AI pilots to deliver measurable impact across the biotech, pharma, and healthcare value chain, from R&D and clinical trials to commercialization, manufacturing, and care delivery. Entries were evaluated on innovation, impact, execution, scalability, and industry relevance. Winners were announced in Fierce Life Sciences' September 2 Special Report. About Claritas Rx Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. Currently celebrating its 15-year anniversary, the company unites the most complete view of the patient journey with purpose-built technologies to predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.

Business Wire

Aug 11th, 2026

Claritas Rx named to the 2026 Inc. 5000 list for the second consecutive year.

Claritas Rx named to the 2026 Inc. 5000 list for the second consecutive year. Recognition Marks the Company's Second Straight Year on the Prestigious List of America's Fastest-Growing Private Companies - and Comes as Claritas Rx Celebrates 15 Years Partnering with Life Sciences Clients SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)-Claritas Rx, the patient journey experts, announced today it has been named to the 2026 Inc. 5000 list for the second consecutive year, earning a place among America's fastest-growing private companies. The list is the most prestigious ranking of the nation's most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, Chobani, Oracle, and Patagonia. "This year is especially meaningful, as it also marks 15 years of Claritas Rx being a trusted partner to our clients. That commitment is what has fueled our growth year after year," said Michael Fitzgibbons, CEO of Claritas Rx. Share The back-to-back honor comes as Claritas Rx marks 15 years in business, a milestone that underscores the company's long-standing role as a trusted partner to biopharma companies working to help patients start and stay on therapy. "We are honored to be named to the Inc. 5000 for the second consecutive year," said Michael Fitzgibbons, CEO of Claritas Rx. "This year is especially meaningful, as it also marks 15 years of Claritas Rx being a trusted partner to our clients. That commitment is what has fueled our growth year after year. Making this list twice in a row is a reflection of the trust our clients place in us, and of a team that stays focused on our promise: progress for every patient journey." For the full Inc. 5000 list, honoree company profiles, and a searchable database by industry and location, please visit: www.Inc.com/Inc5000. "Every company on the Inc. 5000 has a story of perseverance, smart decision making, and a refusal to sit still," says Mike Hofman, editor-in-chief of Inc. "Their growth reflects more than strong financial performance-it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement." About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping its future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.Inc.com. About Claritas Rx Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. Currently celebrating its 15-year anniversary, the company unites the most complete view of the patient journey with purpose-built technologies to predict and resolve access challenges before they disrupt care. Its intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com. More News From Claritas Rx SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, today announced Consent Clearinghouse(TM), a dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma. As biopharma companies navigate an increasingly complex regulatory environment, including HIPAA, GDPR, CCPA, a growing patchwork of state privacy laws, and the emerging rules governing the use of AI, managing patient consent across multiple da... SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, announced new leadership appointments designed to continue growth and scale. The company has welcomed Keith Pensabene as Chief Revenue Officer (CRO) and has promoted Meghna Misra to Vice President, Product and Shelly Howard to Vice President, Customer Operations. Mr. Pensabene brings more than 25 years of executive sales and revenue leadership experience across the life sciences and enterprise software secto... SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, today announced that Bhupesh Bajaj, Chief Technology Officer, has been named to the prestigious PM360 ELITE 100 list in the Data Miners category. The annual recognition highlights the most exceptional, innovative, and transformative leaders shaping the healthcare and life sciences industries today. Mr. Bajaj was recognized for his groundbreaking work redefining how data is harnessed to drive meaningful outco... Claritas Rx. Release Versions

Business Wire

Jun 15th, 2026

Claritas Rx launches Consent Clearinghouse to centralise patient consent management in biopharma

Claritas Rx has launched Consent Clearinghouse, a platform designed to standardise and centralise patient consent management across oncology, rare disease and specialty biopharma. The solution provides a single, auditable source of consent data across multiple touchpoints including hubs, specialty pharmacies and copay programmes. The platform integrates consent data from across a brand's ecosystem into a unified dashboard, offering real-time visibility into consent status at patient, brand and channel levels. It supports compliance with HIPAA, GDPR, CCPA and state privacy laws, whilst enabling seamless integration with existing CRM and pharmacy platforms. South San Francisco-based Claritas Rx designed the solution to address growing regulatory complexity and the operational challenges of managing consent across multiple data sources and channel partners in specialty therapeutics.

Trade Show News

Jun 15th, 2026

Claritas Rx introduces Consent Clearinghouse(TM) to modernize Patient Consent Management across biopharma.

Claritas Rx introduces Consent Clearinghouse(TM) to modernize Patient Consent Management across biopharma. New Solution Gives Oncology and Rare Disease Teams a Centralized, Compliant View of Patient Consent Across the Full Therapy Journey New White Paper from Claritas Rx Entitled "Why Consent Management is Biopharma's Blind Spot" Now Available SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)-Claritas Rx, the patient journey experts, today announced Consent Clearinghouse(TM), a dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma. "Real-time visibility into consent status isn't just about reducing compliance risk today; it's about building the trust infrastructure that will define how brands responsibly scale patient engagement tomorrow," said Mike Fitzgibbons, CEO of Claritas Rx. Share As biopharma companies navigate an increasingly complex regulatory environment, including HIPAA, GDPR, CCPA, a growing patchwork of state privacy laws, and the emerging rules governing the use of AI, managing patient consent across multiple data sources, specialty pharmacies, hubs, and channel partners has become a critical operational and compliance challenge. Consent Clearinghouse addresses this directly by providing a single, auditable source of truth for consent data across all touchpoints. Consent Clearinghouse integrates consent data from across a brand's ecosystem, including hubs, specialty pharmacies, field reimbursement managers, copay programs, and IOD/IDN channels, into a unified dashboard. Commercial and market access teams gain real-time visibility into consent status, enabling them to act on data with confidence while reducing compliance risk. "Commercial and market access teams can no longer afford to operate on fragmented consent data - the pace of AI-driven engagement has raised the stakes too high. Real-time visibility into consent status isn't just about reducing compliance risk today; it's about building the trust infrastructure that will define how brands responsibly scale patient engagement tomorrow," said Michael Fitzgibbons, CEO of Claritas Rx. "We built Consent Clearinghouse to give biopharma teams the visibility and control they need to operate compliantly, move faster, and ultimately serve more patients. This is particularly critical for patients in oncology and rare disease who can't afford delays caused by missing or mismanaged consent." Key Consent Clearinghouse capabilities include: * Unified consent tracking across all patient touchpoints and data sources * Real-time dashboard providing consent status visibility at the patient, brand, and channel level * Audit-ready reporting to support HIPAA, GDPR, CCPA, and state privacy compliance * Seamless integration with existing CRM, hub, and specialty pharmacy platforms * Role-based access controls to protect sensitive patient data across teams and partners With experience supporting numerous brands across oncology, rare, and specialty therapeutic areas, Claritas Rx designed Consent Clearinghouse specifically for the complex, high-stakes environment of specialty and rare disease therapies, where patient access barriers and compliance requirements are greatest. Consent and Compliance Thought Leadership Consent management is no longer just a compliance issue; it is a patient access issue. Claritas Rx's new white paper, "Why Consent Management is Biopharma's Blind Spot," breaks down where consent gaps form, what they cost, and how leading biopharma teams are building a more unified, audit-ready approach across the full therapy journey. A companion webinar, "The Hidden Risk in Your Access Strategy: Rethinking Patient Consent Management," will take place on August 19 at 10 am PT (1 pm ET). Media may request a copy of the white paper or registration to the webinar by contacting Emily Brennan. About Claritas Rx Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete view of the patient journey with purpose-built technologies, Business Wire, Inc. predict and resolve access challenges before they disrupt care. Its intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com. More News From Claritas Rx SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, announced new leadership appointments designed to continue growth and scale. The company has welcomed Keith Pensabene as Chief Revenue Officer (CRO) and has promoted Meghna Misra to Vice President, Product and Shelly Howard to Vice President, Customer Operations. Mr. Pensabene brings more than 25 years of executive sales and revenue leadership experience across the life sciences and enterprise software secto... SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, today announced that Bhupesh Bajaj, Chief Technology Officer, has been named to the prestigious PM360 ELITE 100 list in the Data Miners category. The annual recognition highlights the most exceptional, innovative, and transformative leaders shaping the healthcare and life sciences industries today. Mr. Bajaj was recognized for his groundbreaking work redefining how data is harnessed to drive meaningful outco... SOUTH SAN FRANCISCO, Calif.-( BUSINESS WIRE )-Claritas Rx, the patient journey experts, today announced the availability of its Patient Services Omnichannel CRM. The new solution enables clients to engage rapidly and consistently across the full patient-care ecosystem - from specialty and independent pharmacies to hubs, field teams, case managers, and other key stakeholders - accelerating patient support and streamlining communication for a faster, better experience at every stage of care. By unify... Claritas Rx. Release Versions

Claritas Rx

Business Analyst

About the job